MedPath

Aethlon Medical

Ownership
-
Employees
14
Market Cap
-
Website
Introduction

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

Clinical Trials

5

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (100.0%)

Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device

Not Applicable
Terminated
Conditions
COVID-19
First Posted Date
2020-10-22
Last Posted Date
2022-12-20
Lead Sponsor
Aethlon Medical Inc.
Target Recruit Count
1
Registration Number
NCT04595903
Locations
🇺🇸

Hoag Hospital - Irvine, Irvine, California, United States

🇺🇸

Loma Linda University Medical Center, Loma Linda, California, United States

🇺🇸

Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

and more 6 locations

Hemopurifier Plus Pembrolizumab in Head and Neck Cancer

Not Applicable
Terminated
Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
Device: Hemopurifier
First Posted Date
2020-07-01
Last Posted Date
2022-12-20
Lead Sponsor
Aethlon Medical Inc.
Target Recruit Count
2
Registration Number
NCT04453046
Locations
🇺🇸

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Safety Study of the Aethlon Hemopurifier

Not Applicable
Terminated
Conditions
End Stage Renal Disease
Hepatitis C Infection
First Posted Date
2014-08-13
Last Posted Date
2017-03-14
Lead Sponsor
Aethlon Medical Inc.
Target Recruit Count
8
Registration Number
NCT02215902
Locations
🇺🇸

DaVita Med Center Dialysis, Houston, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.